PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - Springer
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
[引用][C] PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - cir.nii.ac.jp
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - hero.epa.gov
The use of biomarkers for prostate cancer screening, diagnosis and prognosis has the
potential to improve the clinical management of the patients. Owing to inherent limitations of …
potential to improve the clinical management of the patients. Owing to inherent limitations of …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - infona.pl
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
PSA and beyond: alternative prostate cancer biomarkers.
S Saini - Cellular Oncology (2211-3428), 2016 - search.ebscohost.com
Background: The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular oncology (Dordrecht), 2016 - pubmed.ncbi.nlm.nih.gov
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - augusta.elsevierpure.com
Background: The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
PSA and beyond: alternative prostate cancer biomarkers.
S Saini - Cellular Oncology (Dordrecht), 2016 - europepmc.org
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
[HTML][HTML] PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular oncology (Dordrecht), 2016 - ncbi.nlm.nih.gov
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …